Likhami Consult. (539927)
Slow GrowerScore breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹151 |
| Market Cap | ₹153.31 Cr |
| P/E Ratio | 1,000 |
| ROCE | 0.86% |
| ROE | 0.87% |
| Dividend Yield | 0% |
| Profit Growth | 0% |
| Debt/Equity | — |
| Sales Growth | 0% |
| 52-Week Range | ₹269.85 — ₹431 |
| Sector | Commercial Services & Supplies |
| Book Value | ₹34.94 |
Strengths
- Piotroski F-Score of 7/9 is the only positive quantitative signal, suggesting some financial-health indicators are not entirely broken.
- Book value per share of ₹34.94 provides a reported tangible net worth, even though the market cap of ₹153 Cr is far above it.
- The current price of ₹151 is below the stated 52-week range of ₹269.85–₹431.00, which may indicate a sharp de-rating worth investigating if operations ever revive.
Concerns
- Latest quarter shows ₹0 Cr sales and ₹0 Cr net profit; 0% growth is meaningless when the base is zero.
- P/E of 1,000, P/B of 4.32, and PEG of 24 are extreme valuations for a business earning an ROE of only 0.87%.
- No dividend yield and promoter holding not disclosed, leaving shareholders with no income and little transparency.
- The 52-week range sitting entirely above the current price is a red flag of stale data, illiquidity, or a serious loss of confidence.
AI Analysis
At ₹151, Likhami Consult is valued at ₹153 crore. For that price, I get a consulting business whose latest quarter shows ₹0 sales and ₹0 net profit. A trailing P/E of 1,000 is not optimism; it is arithmetic trying to divide something by a near-zero denominator. Graham would ask: where is the earning power? ROE is 0.87%, ROCE is 0.86% — a bank fixed deposit would trounce this. Book value is ₹34.94 per share, and I am asked to pay ₹151, or 4.32 times book, for a business that is not compounding capital. The reported 52-week range of ₹269.85 to ₹431.00 sits entirely above today's price, which is an oddity. That usually means either the data is stale, the stock is illiquid, or the price has suffered a serious rerating. None of these is a margin of safety. Sales and profit growth are 0%, dividend yield is 0%, and promoter holding is unavailable. The Piotroski score of 7/9 provides a small mechanical comfort, but with no profitability and no revenue, I cannot rely on a checklist score. Even the PEG ratio of 24 implies a growth rate that the actual figures do not support. This is a micro-cap shell with no visible moat, no measurable financial strength, and no evidence of shareholder rewards. In Buffett's words, it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price. This is neither wonderful nor fair. I would put it in the 'too hard' pile until it shows sustained revenue, positive earnings, and credible management. I will watch, but I will not buy.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer